Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703747 | SCV000523024 | benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000526571 | SCV000650962 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436280 | SCV002751307 | likely benign | Cardiovascular phenotype | 2018-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001703747 | SCV004010723 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000421903 | SCV004029323 | benign | not specified | 2023-07-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001703747 | SCV004563238 | benign | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003922762 | SCV004748648 | benign | FLNC-related disorder | 2019-06-14 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000421903 | SCV001919373 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000421903 | SCV001927209 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001703747 | SCV001969638 | likely benign | not provided | no assertion criteria provided | clinical testing |